Aspen Neuroscience is a San Diego-based biotechnology company headed by Damian McDevitt, President and CEO. The first product in their clinical pipeline is an autologous neuron replacement therapy for sporadic Parkinson’s disease (ANPD001)
×
Aspen Neuroscience – ANPD001
Receive our NewslEtter
Sign up to stay informed about the latest news and opportunities with LRI!
We respect your privacy. You can unsubscribe at any time.
Use of this Web site constitutes acceptance of the Terms of Use and Privacy Policy.
© 2025 Lifespan Research Institute – ALL RIGHTS RESERVED